Precision BioSciences (FRA:PBS0) FCF Margin % : -108.44% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Precision BioSciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Precision BioSciences's Free Cash Flow for the three months ended in Mar. 2024 was €-17.54 Mil. Precision BioSciences's Revenue for the three months ended in Mar. 2024 was €16.18 Mil. Therefore, Precision BioSciences's FCF Margin % for the quarter that ended in Mar. 2024 was -108.44%.

As of today, Precision BioSciences's current FCF Yield % is -80.98%.

The historical rank and industry rank for Precision BioSciences's FCF Margin % or its related term are showing as below:

FRA:PBS0' s FCF Margin % Range Over the Past 10 Years
Min: -619.32 Med: -380.55 Max: -14.42
Current: -127.57

During the past 7 years, the highest FCF Margin % of Precision BioSciences was -14.42%. The lowest was -619.32%. And the median was -380.55%.

FRA:PBS0's FCF Margin % is ranked better than
51.67% of 1045 companies
in the Biotechnology industry
Industry Median: -143.92 vs FRA:PBS0: -127.57

Precision BioSciences FCF Margin % Historical Data

The historical data trend for Precision BioSciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precision BioSciences FCF Margin % Chart

Precision BioSciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-430.26

-380.55

-14.42

-195.52

-177.30

Precision BioSciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-366.54	-112.49	-179.35	-119.60	-108.44

Competitive Comparison of Precision BioSciences's FCF Margin %

For the Biotechnology subindustry, Precision BioSciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Precision BioSciences's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's FCF Margin % falls into.

Precision BioSciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Precision BioSciences's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-79.222	/	44.683
	=	-177.30 %

Precision BioSciences's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-17.542	/	16.177
	=	-108.44 %

Precision BioSciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Precision BioSciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Precision BioSciences (FRA:PBS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precision BioSciences Inc (FRA:PBS0) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DTIL:USA

Address

302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701

Website

https://www.precisionbiosciences.com

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Precision BioSciences (FRA:PBS0) Headlines

No Headlines